Pharma Stock Market Review

Latest Pharma Stock Updates

Bristol Myers Squibb Acquires Radiopharma Company RayzeBio

Bristol Myers Squibb has added a premier radiopharmaceutical platform to its portfolio with the acquisition of RayzeBio, a radiopharmaceutical therapeutics

Moderna’s ‘Spikevax’ COVID-19 Vaccine Gets Full FDA Approval

The U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed


Evotec Wins € 7.5 Mill Grant for Development of First-in-class COVID-19 Therapeutic

Evotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of


Valneva Stock Price Drops 40% as UK cancels vaccine deal

Valneva shares dropped by around 40% in early trading on Monday as the UK government announced its intention to withdraw

covid shares

Covid Vaccine Shares Hit by US Administration Decision to Wave Patents

The announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious


Evotec Invests in Oxford University Spinout Cell Therapy Company OxVax

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization

drug resistant bacteria

Phico Therapeutics Awarded up to $18.2 Million Funding to Advance Antibacterial Therapy

Phico Therapeutics (‘Phico’), a British biotech company developing engineered phage technologies as the foundation of a new wave of antibiotics

Thermo Fisher to Acquire CRO giant PPD for $17.4 Billion in Cash

Thermo Fisher Scientific expands clinical research service offering to pharma and biotech customers with a CRO giant PPD acquisition. Thermo

Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers

Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $

Phenomic AI starts with $6M using AI/ML for Targeting the Tumor Stroma

Phenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6